As the U.S. stock market takes a breather following a post-election rally, investors are keenly observing opportunities that might arise in different sectors. Penny stocks, despite their somewhat ...
Operations: Cocrystal Pharma, Inc. does not report any specific revenue segments. Market Cap: $18.01M Cocrystal Pharma, Inc., with a market cap of US$18.01 million, is a pre-revenue biotechnology ...